<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-G2MPC06001MV</udiDi>
    <basicUdiDi>B-G2MPC06001MV</basicUdiDi>
    <tradeName>Pan Cancer Panel</tradeName>
    <deviceName>Pan Cancer Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MPC06001-ill,G2MPC06001-MG, G2MPC06001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:46:13.292Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MOC01001L9</udiDi>
    <basicUdiDi>B-G2MOC01001L9</basicUdiDi>
    <tradeName>Onco Check Panel</tradeName>
    <deviceName>Onco Check Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MOC01001-ill; G2MOC01001-TF; G2MOC01001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:46:08.481Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MMSP08001XR</udiDi>
    <basicUdiDi>B-G2MMSP08001XR</basicUdiDi>
    <tradeName>Med4Me Standard Panel</tradeName>
    <deviceName>Med4Me Standard Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W010699</emdnCode>
    <emdnDescription>GENETIC TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MMSP08001-ill,G2MMSP08001-MG,G2MMSP08001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:46:07.785Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MML28001R3</udiDi>
    <basicUdiDi>B-G2MML28001R3</basicUdiDi>
    <tradeName>Myeloid Leukemia NGS Panel</tradeName>
    <deviceName>Myeloid Leukemia NGS Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MML28001-ill, G2MML28001-MG, G2MML28001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:52.429Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MLYM31001YM</udiDi>
    <basicUdiDi>B-G2MLYM31001YM</basicUdiDi>
    <tradeName>Lymphoma NGS Panel</tradeName>
    <deviceName>Lymphoma NGS Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MLYM31001-ill, G2MLYM31001-MG, G2MLYM31001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:50.830Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MLL30001P5</udiDi>
    <basicUdiDi>B-G2MLL30001P5</basicUdiDi>
    <tradeName>Lymphoid Leukemia NGS Panel</tradeName>
    <deviceName>Lymphoid Leukemia NGS Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MLL30001-ill, G2MLL30001-MG, G2MLL30001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:50.721Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MHLA32001JP</udiDi>
    <basicUdiDi>B-G2MHLA32001JP</basicUdiDi>
    <tradeName>HLA Typing NGS Panel</tradeName>
    <deviceName>HLA Typing NGS Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MHLA32001-ill; G2MHLA32001-MG; G2MHLA32001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:45.217Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCTLP1300154</udiDi>
    <basicUdiDi>B-G2MCTLP1300154</basicUdiDi>
    <tradeName>ctDNA Lung Panel</tradeName>
    <deviceName>ctDNA Lung Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCTLP13001-ill,G2MCTLP13001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:44.417Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCTCP11001XS</udiDi>
    <basicUdiDi>B-G2MCTCP11001XS</basicUdiDi>
    <tradeName>ctDNA Colorectal Panel</tradeName>
    <deviceName>ctDNA Colorectal Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCTCP11001-ill, G2MCTCP11001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:42.980Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCTBP12001XG</udiDi>
    <basicUdiDi>B-G2MCTBP12001XG</basicUdiDi>
    <tradeName>ctDNA Breast Panel</tradeName>
    <deviceName>ctDNA Breast Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCTBP12001-ill,G2MCTBP12001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:42.009Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCHC24001EH</udiDi>
    <basicUdiDi>B-G2MCHC24001EH</basicUdiDi>
    <tradeName>Common Hereditary Cancer NGS Panel</tradeName>
    <deviceName>Common Hereditary Cancer NGS Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCHC24001-ill,G2MCHC24001-MG,G2MCHC24001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:35.609Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCES07001KD</udiDi>
    <basicUdiDi>B-G2MCES07001KD</basicUdiDi>
    <tradeName>Clinical Exome Sequencing (CES) Expanded Panel</tradeName>
    <deviceName>Clinical Exome Sequencing (CES) Expanded Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W010699</emdnCode>
    <emdnDescription>GENETIC TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCES07001-ill G2MCES07001-MG G2MCES07001-TF G2MCES07001(WES) ill G2MCES07001(WES) MG G2MCES07001(WES) TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:34.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCC03001EB</udiDi>
    <basicUdiDi>B-G2MCC03001EB</basicUdiDi>
    <tradeName>CancerCheck 50 Panel</tradeName>
    <deviceName>CancerCheck 50 Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCC03001-ill; G2MCC03001-TF; G2MCC03001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:34.005Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MCC02001E4</udiDi>
    <basicUdiDi>B-G2MCC02001E4</basicUdiDi>
    <tradeName>CancerCheck Core Panel</tradeName>
    <deviceName>CancerCheck Core Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MCC02001-ill; G2MCC02001-TF; G2MCC02001-MG</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:28.705Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2MBR00001K8</udiDi>
    <basicUdiDi>B-G2MBR00001K8</basicUdiDi>
    <tradeName>BRCA 1/2 Panel</tradeName>
    <deviceName>BRCA 1/2 Panel</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060203</emdnCode>
    <emdnDescription>BRCA 1+2</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2MBR00001-ill,G2MBR00001-MG,G2MBR00001-TF</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:27.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2M803421FH</udiDi>
    <basicUdiDi>B-G2M803421FH</basicUdiDi>
    <tradeName>Thrombosis-Q Comprehensive Real Time PCR Kit</tradeName>
    <deviceName>Thrombosis-Q Comprehensive Real Time PCR Kit</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010114</emdnCode>
    <emdnDescription>PROTHROMBIN MUTATION</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2M803421, G2M803421R</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:11.588Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2M803321FC</udiDi>
    <basicUdiDi>B-G2M803321FC</basicUdiDi>
    <tradeName>BT-Q Real Time PCR Kit (Beta Thalassemia)</tradeName>
    <deviceName>BT-Q Real Time PCR Kit (Beta Thalassemia)</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010111</emdnCode>
    <emdnDescription>THALASSAEMIA</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2M803321,G2M803321R</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:08.382Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2M803221F7</udiDi>
    <basicUdiDi>B-G2M803221F7</basicUdiDi>
    <tradeName>SCA-Q Real Time PCR Kit (Sickle Cell Anemia)</tradeName>
    <deviceName>SCA-Q Real Time PCR Kit (Sickle Cell Anemia)</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010109</emdnCode>
    <emdnDescription>SICKLE CELL ANEMIA</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2M803221,G2M803221R</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:45:07.610Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2M803021EV</udiDi>
    <basicUdiDi>B-G2M803021EV</basicUdiDi>
    <tradeName>YCM-Q Real Time PCR Kit (Y Chromosome Microdeletion)</tradeName>
    <deviceName>YCM-Q Real Time PCR Kit (Y Chromosome Microdeletion)</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2M803021,G2M803021R</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:44:51.579Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-G2M802721FR</udiDi>
    <basicUdiDi>B-G2M802721FR</basicUdiDi>
    <tradeName>BCR-ABL Universal Real Time PCR Kit</tradeName>
    <deviceName>BCR-ABL Universal Real Time PCR Kit</deviceName>
    <manufacturerName>Genes 2Me Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000035953</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01060299</emdnCode>
    <emdnDescription>TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>G2M802721,G2M802721R</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:44:49.667Z</lastUpdated>
  </row>
</eudamedExport>